United States News Todas as matérias

United Therapeutics (NASDAQ:UTHR) acquired Thymmune Therapeutics, a preclinical biotechnology company focused on regenerative thymic cell therapies for immune-related diseases.

Ryanair (NASDAQ:RYAAY) reported a 7% increase in June traffic to a new record of 21.2 million guests.

Woodside Energy Group (NYSE:WDS) announced that non-executive director Tony O’Neill will resign from the board effective 1 July 2026.

VEON (NASDAQ:VEON) and Mastercard (NYSE:MA) announced a partnership aimed at expanding access to digital financial services in Ukraine, Kazakhstan, Pakistan, and Uzbekistan.

The Ensign Group (NASDAQ:ENSG) acquired the operations of two skilled nursing facilities in Texas, expanding its healthcare portfolio in the U.S. senior care market.

iQIYI (NASDAQ:IQ) announced a leadership change, appointing Ying Tian as Chief Financial Officer effective July 2, 2026.

Alphabet (NASDAQ:GOOGL) lost its final appeal after the Court of Justice of the European Union upheld a €4.1 billion fine tied to Google’s Android operating system practices.

HUTCHMED (NASDAQ:HCM) received conditional approval from China’s National Medical Products Administration for ORPATHYS® (savolitinib) to treat certain advanced gastric and gastroesophageal junction cancers.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that the U.S. Food and Drug Administration has approved expanded use of CASGEVY (exagamglogene autotemcel) for the treatment of people ages 2 years and older with either sickle cell disease with recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

Telix (NASDAQ:TLX) said the U.S. Food and Drug Administration agreed that safety data from Part 1 of its ProstACT Global Phase 3 trial support progression into Part 2 in the United States.

Abbisko Therapeutics and AstraZeneca (NYSE:AZN) entered a strategic collaboration to develop a combination therapy for patients with EGFR-mutated, PD-L1 positive non-small cell lung cancer (NSCLC).

General Motors (NYSE:GM) reported a 4.2% year-on-year decline in U.S. auto sales for the second quarter, with total deliveries of 714,896 vehicles compared with 746,588 units in the prior-year period.

UniFirst (NYSE:UNF) reported fiscal third-quarter 2026 revenue of $634.4 million, reflecting 3.9% growth compared with the same period last year.

The Patent and Market Court in Stockholm delivered a judgment on Wednesday ordering Alphabet (NASDAQ:GOOGL) to pay 14.3 billion Swedish kronor (€1.3 billion) in antitrust damages.

Meta Platforms (NASDAQ:META) is building an internal cloud infrastructure business to sell excess artificial intelligence computing capacity after its shares rose over 6% in premarket trading.

Artelo Biosciences (NASDAQ:ARTL) reported new preclinical data for ART26.12, a selective FABP5 inhibitor currently in Phase 1 development, in a mouse model of spinal cord injury–related neuropathic pain.

Micron (NASDAQ:MU) and General Motors (NYSE:GM) signed a Strategic Customer Agreement to secure long-term supply of automotive memory and storage for GM’s next-generation vehicle platforms

60 Degrees Pharma (NASDAQ:SXTP) reported that an independent Data Safety Monitoring Board found no safety concerns in the first six patients in its Phase 2 B-Free chronic babesiosis study and recommended trial continuation.

Himax Technologies (Nasdaq:HIMX) said it plans to dispose of its investment in an equity-method investee after the startup agreed to be acquired by a third-party semiconductor company for $80 million in cash.

BTQ (NASDAQ:BTQ) received final approval from French foreign direct investment authorities to acquire all remaining shares of QPerfect, a quantum software company based in Strasbourg.

Vyome Holdings (NASDAQ:HIND) said the China National Intellectual Property Administration granted a patent covering formulation and therapeutic uses for its besifloxacin topical gel program.

Arrow Financial (NASDAQ:AROW) announced the completion of its strategic acquisition of Adirondack Bancorp and the merger of Adirondack Bank into Arrow Bank National Association.

FactSet (NYSE:FDS) reported third-quarter fiscal 2026 revenue of $622.9 million, representing a 6.4% increase year over year with 7% organic revenue growth.

Intensity Therapeutics (NASDAQ:INTS) issued a mid-year 2026 update on its intratumoral cancer therapy INT230-6, highlighting progress across late-stage clinical programs.